Why Insulin Resistance Is a Hormone Problem
Insulin resistance — the condition in which cells fail to respond normally to insulin, requiring ever-higher insulin levels to maintain blood glucose — is most commonly discussed in the context of type 2 diabetes and metabolic syndrome. But its effects extend deeply into the entire hormonal system, contributing to low testosterone in men, PCOS in women, thyroid dysfunction, growth hormone resistance, and weight gain that further perpetuates the cycle. Addressing insulin resistance is often the key that unlocks hormonal optimization for patients who are not responding adequately to hormone therapy alone.
Insulin Resistance and Testosterone in Men
The relationship between insulin resistance and low testosterone in men is bidirectional and self-reinforcing. Elevated insulin and elevated blood glucose suppress the hypothalamic-pituitary axis, reducing LH secretion and Leydig cell testosterone output. Simultaneously, high insulin drives aromatase activity in adipose tissue — accelerating conversion of testosterone to estradiol — further reducing the testosterone-to-estrogen ratio.
Conversely, low testosterone promotes central adiposity (abdominal fat), which is both a cause and consequence of insulin resistance — creating a feedback loop where low T leads to more fat, which causes more insulin resistance, which further suppresses testosterone. Breaking this cycle requires addressing both hormones and metabolic health simultaneously.
Insulin Resistance and PCOS in Women
Polycystic ovary syndrome (PCOS) — affecting 8–13% of women of reproductive age — is fundamentally a condition of insulin resistance in most cases. Elevated insulin stimulates the ovaries to produce excess testosterone (hyperandrogenism), suppresses SHBG production (increasing free androgens), and disrupts normal follicular development and ovulation. The result: irregular cycles, elevated androgens, and often — though not universally — polycystic ovarian morphology on ultrasound.
Treating PCOS without addressing insulin resistance produces incomplete results. Metformin, inositol supplementation, low-glycemic diets, and GLP-1 agonists like semaglutide all improve PCOS symptoms by improving insulin sensitivity — and are often more effective than hormonal birth control (which treats symptoms rather than root cause) in the long term.
Insulin Resistance and Thyroid Function
Insulin resistance impairs T4-to-T3 conversion by reducing the activity of deiodinase enzymes that perform this conversion. Simultaneously, hyperinsulinemia increases thyroid-binding globulin, reducing free thyroid hormone availability. The result is functional hypothyroid symptoms — fatigue, cold intolerance, weight gain, brain fog — in patients with apparently normal thyroid labs who have significant metabolic dysfunction.
Addressing Insulin Resistance Alongside Hormone Therapy
At Multigen Wellness, fasting insulin and glucose (with HOMA-IR calculation) are included in the baseline metabolic panel for all patients — because insulin resistance status fundamentally affects both hormone optimization strategy and expected treatment response. Patients with significant insulin resistance are supported with dietary guidance (reduced refined carbohydrate intake, increased fiber, improved meal timing), exercise recommendations, and when clinically appropriate, GLP-1 agonist therapy (semaglutide or tirzepatide), which directly improves insulin sensitivity alongside producing weight loss.
Comprehensive hormone optimization addresses the full metabolic picture, not just hormone levels in isolation. Call Multigen Wellness at (800) 259-0015 to schedule a complete evaluation.